key: cord-1016306-zwesftfs
authors: Lin, Jason; Nakamura, Yohko; Mikami, Haruo; Kusakabe, Miho; Saruki, Nobuhiro; Wakao, Fumihiko; Nagase, Hiroki
title: Matters of data openness and KapWeb, a web tool of multi‐cancer survival analysis for cancer survivors
date: 2021-03-10
journal: Cancer Sci
DOI: 10.1111/cas.14788
sha: 86b7aaf5c5b165a5f6ea31b95297917bed50f2dd
doc_id: 1016306
cord_uid: zwesftfs

KapWeb is an interactive tool for the determination of cancer survival rates based on case outcomes compiled from more than half a million records from cancer registries all over Japan, and we believe that both the tool and the call for data openness and transparency are important.[Image: see text]

Dear Editors,

The year 2020 had been a challenging year especially for the medical community, as the coronavirus pandemic has caused much disruption to key healthcare areas such as cancer care. 1 KapWeb also includes a unique feature in generating a conditional survival rate, which we term CSSR, Figure 2A The shakeup of 2020 is irreversibly transforming our lives, as we become acquainted with mask wearing and social distancing. Certainly, these changes will affect how the medical community provides cancer care, as we move forward and readjust to a new normal. Cancer will always be a public health issue, and a key element in maintaining order with public health problems is the instillation of confidence, which can only come with greater transparency and openness. In this grand scheme, while tools such as KapWeb may seem inconsequential, but just like the simple act of wearing masks as a COVID-19 countermeasure, when every little incremental step helps, then as the English F I G U R E 1 KapWeb interface and sample output. A, "Simple Data" mode parameter selection window. B, "Full Data" access mode parameter options, with expanded options over Simple Data mode highlighted in red. C, Sample relative 10-y survival rate output for Stage III breast cancer cases (N = 1650) between 2002 and 2012; note that changes in survival rate remain relatively constant over this period F I G U R E 2 Utility of cancer survivor's survival rate (CSSR). Example comparisons of CSSR and actual survival rates for all stages of (A) breast and (B) colorectal cancers registered between 1997 and 2012 among female patients 15-94 y of age. Dark blue circle, CSSR (N = 71 465 and 20 827 for breast and colorectal cancers, respectively); dark red diamonds, actual (corrected for demographics, dashed line) and relative (solid line) survival rates (N = 72 697 and 23 012 for breast and colorectal cancers, respectively). C, trends in 5-y CSSR per annum for lung cancers (1997) (1998) (1999) (2000) (2001) (2002) (2003) (2004) (2005) (2006) (2007) (2008) (2009) (2010) (2011) (2012) . Red, all ages; green, ages between 60 and 69. KapWeb statistics shown were conditionally adjusted to reflect a lapse period of 330 d after the initial diagnosis and rendered in R; shaded regions indicate 90% confidence intervals for the relative rates

The impact of the COVID-19 pandemic on cancer deaths due to delays in diagnosis in England, UK: a national, population-based, modelling study

Can Initiative. Patient insights on cancer care: opportunities for improving efficiency

Lack of patient-clinician concordance in cancer patients: Its relation with patient variables

chiba -cance r-regis try.org

Survival statistics publication and web-based calculation publication of survival rates by the Japanese Association of Clinical Cancer Centers

Establishing a quality measurement system for cancer care in Japan

The relative survival rate: a statistical methodology

Instructions to IBM 650 Programmers in Processing Survival Computations

Comparison of different approaches to estimating age standardized net survival

Choosing the relative survival method for cancer survival estimation

Hiroki Nagase https://orcid.org/0000-0002-3992-5399